GPCR Live signals | Maximize Profits with Getagraph.com

BUY 152068 min ago

@ $46.21

Issued: 14 Feb 2024 @ 12:06

Return: -21.61%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: -4.71 %

Live Chart Being Loaded With Signals

Commentary (29 May 2024 @ 16:00):

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs...

Stats
Today's Volume	291 324
Average Volume	607 252
Market Cap	1.69B
EPS	$0 ( 2024-05-09 )
Next earnings date	( $-0.230 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-16.10
ATR14	$0.0560 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Fmr Llc	Buy	0
2024-03-15	Lin Xichen	Buy	213 486	Stock Option (right to buy)
2024-03-15	Bach Mark Allen	Buy	65 352	Stock Option (right to buy)
2024-03-15	Ma Yingli	Buy	91 494	Stock Option (right to buy)
2024-03-15	Yoon Jun	Buy	148 134	Stock Option (right to buy)

INSIDER POWER
31.27
Last 43 transactions
Buy: 9 065 015 \| Sell: 6 065 489

Volume Correlation

Long: 0.03 (neutral)

Short: -0.98 (very strong negative)

Signal:(33.6) Neutral

Structure Therapeutics Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Structure Therapeutics Correlation - Currency/Commodity

0.29
( neutral )

0.38
( neutral )

0.00
( neutral )

0.76
( moderate )

-0.61
( weak negative )

0.02
( neutral )

Structure Therapeutics Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-949 174 (0.00 %)
EPS:	$-2.44

FY	2023
Revenue:	$0
Gross Profit:	$-949 174 (0.00 %)
EPS:	$-2.44

FY	2022
Revenue:	$0
Gross Profit:	$-623 258 (0.00 %)
EPS:	$-1.400

Financial Reports:

No articles found.

Structure Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Structure Therapeutics

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.